If you enjoy this content, please share it with a colleague
RELATED CONTENT
September 21, 2021 — HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently ...
The promise of personalized medicine, with its potential for treatments tailored to individual patients’ genomic ...
HealthMyne announced the release of Quantitative Imaging Decision Support (QIDS) 5 featuring a new, automated Cancer Screening Module. The module is designed for tracking, communicating and reporting on patients who may be at a higher risk for developing cancer.
November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate the ...
October 18, 2017 — HealthMyne announced the release of QIDS (Quantitative Imaging Decision Support) 3.0 with the ...
HealthMyne has partnered with Gilda’s Club of Madison (Wis.) in an effort to make a difference in the lives of children and adults living with cancer during the 2016 Radiological Society of North America (RSNA) annual meeting.
HealthMyne will be unveiling and providing demonstrations of their new Quantitative Imaging Decision Support (QIDS) commercial platform at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 1 in Chicago.
HealthMyne, an imaging informatics company, announced 510(k) clearance from the U.S. Food and Drug Administration (FDA). The new analytics software package is designed to provide radiologists with significant workflow efficiencies related to oncology cases, as well as advanced decision support.
Imaging informatics company HealthMyne announced a major advance in their quantitative imaging analytics platform. Working together with Epic and University of Wisconsin (UW) Health, HealthMyne now offers radiologists a unification of electronic health record (EHR) data and imaging information.